Chronic Idiopathic Constipation Treatment Market:
Introduction
According to the report, the global chronic
idiopathic constipation treatment market was valued over
US$ 7.8 Bn in 2019. It is projected to expand at a CAGR of ~7%
from 2020 to 2030. Constipation is a common condition that occurs when bowel
movement becomes less frequent and stools become difficult to pass. Chronic
idiopathic constipation is a type of constipation. It is categorized by
infrequent stools that are often difficult to pass. It is specifically affects
older adults and women. The global chronic idiopathic constipation treatment
market is expanding due to significant investments by key players. Investments
by key players to strengthen their product portfolios through acquisitions,
mergers, and collaborations create significant opportunities in the market. The
adoption of newer therapeutics is fueling the demand for advanced products.
This represents a new business development opportunity.
Chronic Idiopathic Constipation Treatment Market:
Regional Overview
North America dominated the global chronic idiopathic constipation
treatment market in 2019. The trend is anticipated to continue during the
forecast period. Strategies adopted by key players, such as product approval
& launch and mergers & acquisitions, well-established healthcare
infrastructure, and early adoption of advanced therapeutics boost the chronic
idiopathic constipation treatment market in the region. Asia Pacific is likely
to be a highly lucrative market for chronic idiopathic constipation treatment.
The market in the region is expected to expand at a high CAGR during the
forecast period. Government initiatives in developing countries toward
modernization of healthcare infrastructure and rise in awareness about advanced
therapeutics are key factors that are anticipated to fuel the chronic
idiopathic constipation treatment market in Asia Pacific.
Request COVID Analysis on Chronic
Idiopathic Constipation Treatment Market –
https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=20537
Focus on R&D to Drive Chronic Idiopathic
Constipation Treatment Market
Increase in R&D activities and expenditure on new products and
therapeutics development are expected to drive the chronic idiopathic
constipation treatment market. Moreover, rise in pharmaceutical R&D budgets
by both governments and private players to support new product and technology
development is anticipated to drive the demand for chronic idiopathic
constipation treatment products.
Stimulants to Dominate Global Market
In terms of type, the global chronic idiopathic constipation treatment
market has been classified into Serotonin-4 (5-Ht4)
Receptor Agonist, Guanylate Cyclase-C Agonist, laxatives, stimulants, and
others. The stimulants segment accounted for a major share of the market. It is
likely to maintain its dominance during the forecast period. Effectiveness of
stimulant laxatives in the treatment of constipation is increasing the use of
products and subsequently, driving the segment.
Request Customization on Chronic Idiopathic Constipation Treatment Market
Report –
https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=20537
Oral Route of Administration Preferred by Patients
In terms of route of administration, the global chronic idiopathic
constipation treatment market has been divided into oral and rectal. The oral
segment dominated the global market in 2019. It is anticipated to expand at a
rapid pace during the forecast period. The introduction of new formulations
administered through the oral route is likely to fuel the segment. For instance,
in 2020, the U.S. Food and Drug Administration (FDA) has approved lactitol
(Pizensy) osmotic laxative recommended dosage of 20 grams
orally, daily, for the treatment of CIC.
Retail Pharmacies to be Key Distribution Channel
In terms of distribution channel, the global chronic idiopathic
constipation treatment market has been divided into hospital pharmacies, retail
pharmacies, and online pharmacies. Surge in number of retail pharmacies due to
preference for distribution through retail pharmacy is likely to propel the
segment.
North America to Dominate Chronic Idiopathic
Constipation Treatment Market
In terms of region, the global chronic idiopathic constipation treatment
market has been segmented into North America, Europe, Asia Pacific, Latin
America, and Middle East & Africa. North America dominated the global
chronic idiopathic constipation treatment market in 2019, followed by Europe.
North America accounted for a major share of the global chronic idiopathic
constipation treatment market in 2019. Presence of key players and focus on
research & development are key factors anticipated to drive the chronic
idiopathic constipation treatment market in the region. Moreover, approval of
products, i.e., TRULANCE is likely to augment the market. The chronic idiopathic
constipation treatment market in Asia Pacific is anticipated to expand at a
rapid pace during the forecast period. Increase in investment by key players is
likely propel the market.
Buy Chronic
Idiopathic Constipation Treatment Market Report-
https://www.transparencymarketresearch.com/checkout.php?rep_id=20537<ype=S
Competition Landscape
The global chronic idiopathic constipation treatment market is
fragmented in terms of number of players. Key players in the global chronic
idiopathic constipation treatment market include Bayer AG, Allergan,
Bausch Health, Sanofi, Takeda Pharmaceutical Company, SEBELA PHARMACEUTICALS,
Ironwood Pharmaceuticals, Inc., Albireo Pharma, Inc., Sucampo Pharmaceuticals,
Inc. (Mallinckrodt), and Janssen Pharmaceuticals, Inc. (Johnson & Johnson).
Global Chronic Idiopathic Constipation Treatment
Market: Segmentation
·
·
o
o
·
o
o
·
o
o
o
·
o
o
o
·
·
·
·
·
·
·
·
·
·
o
o
·
o
o
o
o
o
o
·
o
o
o
o
o
·
o
o
o
·
o
o
o
About Us
Transparency Market Research is a global market intelligence company, providing
global business information reports and services. Our exclusive blend of
quantitative forecasting and trends analysis provides forward-looking insight
for thousands of decision makers. Our experienced team of analysts,
researchers, and consultants, uses proprietary data sources and various tools
and techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research
experts, so that it always reflects the latest trends and information. With a
broad research and analysis capability, Transparency Market Research employs
rigorous primary and secondary research techniques in developing distinctive
data sets and research material for business reports.
Contact
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com
